Curi Bio & Battelle Partner to Advance Neuromuscular Drug Testing
Strategic Collaboration to Accelerate Human-Relevant Neuromuscular Testing Curi Bio and Battelle have announced a strategic collaboration aimed at transforming the field of neuromuscular pharmacology through the accelerated adoption of New Approach Methods (NAMs). This partnership represents a significant step forward…
AmeriPro Health Teams Up with Orion Talent to Boost Veteran Hiring in EMS Operations
AmeriPro Health Partners with Orion Talent to Boost Veteran Hiring in EMS AmeriPro Health has taken a significant step in strengthening its workforce and expanding its national footprint by announcing a strategic partnership with Orion Talent. This collaboration is focused…
Aptar’s Unidose Nasal Powder System Featured in Phase II Study of ENA’s INNA-051 Nasal Spray
Aptar’s Introduction to INNA-051 Investigational Nasal Spray AptarGroup a global leader in drug delivery, dosing, and protection technologies, has announced the use of its Unidose (UDS) Powder Nasal Spray System in a Phase II clinical study being conducted by ENA…
Innovive Health Expands Behavioral Health Home Care Services in Colorado
Innovive Health Expands Behavioral Home Healthcare Services Across Key Regions in Colorado to Support Vulnerable Populations Innovive Health, a leading provider of specialized home healthcare services for patients with complex behavioral health conditions and coexisting medical needs, has announced a…
Kardigan Showcases Late-Stage Precision Cardiovascular Portfolio at ACC.26
Kardigan to Present Late-Stage Cardiovascular Pipeline and AI-Driven Insights at ACC.26 Kardigan, a company focused on transforming heart health through innovative drug development, has announced multiple presentations at the ACC.26. The event will take place from March 28 to March…
Exact Sciences to Showcase MRD and Multi-Cancer Detection Data at AACR 2026
Exact Sciences Highlights Advances in MRD and Multi-Cancer Early Detection at AACR 2026 Exact Sciences Corp. is set to present significant new data at the AACR Annual Meeting 2026, underscoring its continued leadership in cancer diagnostics and precision oncology. The…
Fulgent Genetics completes acquisition of Bako Diagnostics and StrataDx
Fulgent Genetics finalizes $56.9 million deal to expand pathology and dermatopathology capabilities with Bako Diagnostics and StrataDx Fulgent Genetics, Inc., a technology-driven company known for its strong laboratory services platform and growing therapeutic development efforts, has officially completed its previously…
Aarvik Therapeutics Presents New ADC Molecules at AACR 2026
Aarvik Therapeutics Unveils Novel ADCs at AACR 2026 Aarvik Therapeutics, a biotechnology company focused on advancing antibody-drug conjugate (ADC) technologies, has announced its participation in the AACR Annual Meeting 2026, where it will present multiple scientific findings highlighting its innovative…
Verastem Oncology to Present Abstracts at AACR 2026 Meeting
Verastem Oncology Highlights Promising Preclinical Data and Multiple Abstract Presentations at AACR 2026 Verastem Oncology has announced the acceptance of multiple late-breaking and regular abstracts for presentation at the AACR Annual Meeting 2026, scheduled to take place from April 17–22,…
WuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Bioprocessing, Manufacturing, and Digital Innovation Leadership
WuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Advancements in Bioprocessing, Manufacturing Quality, and Digital Innovation WuXi Biologics a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two individual…
Johnson & Johnson Secures FDA Approval for TECNIS PureSee Intraocular Lens to Improve Cataract Vision in the U.S.
Johnson & Johnson Secures U.S. Food and Drug Administration Approval for TECNIS PureSee Intraocular Lens, Expanding Vision Care Options for U.S. Cataract Patients Johnson & Johnson announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth…
Eli Lilly and Company Issues Safety Warning on Tirzepatide Compounded with Vitamin B12
Eli Lilly and Company Issues Open Letter Warning About Potential Patient Safety Risks of Tirzepatide Compounded with Vitamin B12 Lilly is issuing a public warning about potential safety risks associated with compounded tirzepatide mixed with vitamin B12. As part of…